Home International Trading News Blue Chips, Small Mid Cap
Blue Chips, Small Mid Cap PDF Print E-mail
Trading News - International Trading News

BLUE CHIPS COMPANY NEWS
- adp (Hold) September traffic up 5.2%
- Banco Popular  (Buy) 9m’10 results preview
- Banco Santander (Buy) Agreement in which Qatar Holding takes 5% Santander Brasil.
- Carlsberg (Accumulate) The glass is filled up for now
- Celesio (Hold) Anzag sold / Downgrade to HOLD
- Dassault Aviation (Buy) 9M-2010 sales
- EFG Eurobank Ergasias (Hold) Completion of an interbank repo agreement with GGBs
- Finmeccanica (Accumulate) British PM due to unveil the “spending review” today
- FondiariaSai (Accumulate) Improving outlook on motor insurance avoids the need of disposing Liguria-Sasa according to press
- Fortum (Accumulate) Hedge ratio and price for 2012 in key focus
- Fraport (Buy) Strong Q3 2010 expected
- Hugo Boss (Hold) Recovery underestimated – too late to turn positive
- Iberdrola Renovables (Buy) Good results in renewable. Less investments in 2011
- Novo Nordisk (Accumulate) Possible entrance of a new competitor in insulin
- OPAP (Buy) Three scenarios to commence online operations
- Technip (Accumulate) Marine well containment system contract in the US
- Terna (Accumulate) “O’ sole mio”
- Terna (Accumulate) Interim dividend ahead of expectations
- UniCredit (Accumulate) Agreement with unions on Italian redundancies

SMALL & MID CAPS COMPANY NEWS
- Beni Stabili  (Buy) Extraordinary shareholders’meeting called to be SIIQ
- Cir (Hold) Sorgenia Q3 10 results
- DOCDATA (Accumulate) Records loss in Q3
- Dockwise (Buy) Dockwise client orders 6 new rigs
- Havas (Hold) A reassuring Q3-10 after a disappointing Q2-10
- Itelligence (Accumulate) 3Q10 preview
- Konecranes (Buy) Q3 service orders a focus point – turnaround in new equipment orders likely to continue
- Kontron (Accumulate) 3Q10 preview / momentum play - PT up EUR to EUR 8 (7)
- Meda (Buy) If not 2025, what about 2013?
- Mediq (Buy) Alliance Boots will launch tender offer for Anzag
- Morphosys (Buy) Second Pre-Development Program with Novartis
- Omega Pharma (Accumulate) 3Q10 sales preview
- Origin Enterprises (Accumulate) Yara results ahead on improved margins and volumes
- Orpéa (Buy) Acquisition will reinforce capacity to expand
- Outotec (Buy) Orders likely to exceed consensus expectations; earnings should take off, too
- Sipef (Accumulate) 3Q10 trading update preview – TP lifted to EUR 62 on higher CPO & rubber prices
- Sogefi (Hold) Positive Q3 10 results due today
- Steria (Buy) Q3 sales higher than forecast, but FY guidance lower than the consensus
- TI Media (Accumulate) Q3 preview: solid quarter expected
- Transgène (Hold) Cash consumption in line with Q3-2010

 

Admiral Markets - Forex Broker.


Top 5 Volumi Up

Top 5 Volume Down

StockMarket Index